Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance

NCT04071613 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Stroke, Acute, Stroke Ischemic

Interventions

DRUG: Tenecteplase
DRUG: Intravenous tissue plasminogen activator (tPA)

Sponsor

Melbourne Health